Achillion Pharmaceuticals Inc. | Key People and Executives
Joseph Truitt
President, Chief Executive Officer & Director
Michael D. Kishbauch
Independent Director
Robert L. van Nostrand
Independent Director
Frank A. G. M. Verwiel
Independent Director
Kurt C. Graves
Independent Director
Jason S. Fisherman
Independent Director
Nicole Vitullo
Independent Director
Joseph Truitt
President, Chief Executive Officer & Director
Paul Firuta
Chief Operating Officer & Executive Vice President
Mary Kay Fenton
CFO, Principal Accounting Officer & Executive VP
Steven L. Zelenkofske
Chief Medical Officer & Executive Vice President
Mingjun Huang
Senior Vice President & Head-Research
Laura Barrow
Vice President-Clinical Operations
Anthony S. Gibney
Chief Business Officer & Executive Vice President
Brian R. DiDonato
VP-Investor Relations & Corporate Communications
Liz Power
Media Relations Contact
Glenn Schulman
Investor Relations Contact
Ky Nam-Wortman
Vice President & Head-Human Resources
Martha E. Manning
Secretary, Executive VP & General Counsel
Michael D. Kishbauch
Independent Director
Robert L. van Nostrand
Independent Director
Frank A. G. M. Verwiel
Independent Director
Kurt C. Graves
Independent Director
Jason S. Fisherman
Independent Director
Nicole Vitullo
Independent Director
| Address |
VEVA Building 14
Blue Bell Pennsylvania 19422
United States
|
|
Employees
|
- |
| Website |
http://www.achillion.com |
| Updated |
07/08/2019 |
| Achillion Pharmaceuticals, Inc. engages in the discovery and development of small molecule drug therapies for immune system disorders. It offers its propriety platform of potent and specific complement factor D inhibitors for AP-mediated diseases. The company was founded on August 17, 1998 and is headquartered in New Haven, CT. |
